460
Views
1
CrossRef citations to date
0
Altmetric
REVIEW

Iron Deficiency and Blood Donation: Links, Risks and Management

ORCID Icon, , ORCID Icon, &
Pages 775-786 | Received 24 Sep 2022, Accepted 05 Dec 2022, Published online: 10 Dec 2022

References

  • Reiss RF. Blood donor well-being: a primary responsibility of blood collection agencies. Ann Clin Lab Sci. 2011;41(1):3–7.
  • Goldman M, Uzicanin S, Scalia V, O’Brien SF. Iron deficiency in Canadian blood donors. Transfusion. 2014;54(3pt2):775–779. doi:10.1111/trf.12380
  • Boulton F. Managing donors and iron deficiency. Vox Sang. 2004;87(s2):22–24. doi:10.1111/j.1741-6892.2004.00448.x
  • Mast AE, Langer JC, Guo Y, et al. Genetic and behavioral modification of hemoglobin and iron status among first‐time and high‐intensity blood donors. Transfusion. 2020;60(4):747–758. doi:10.1111/trf.15743
  • Pratt JJ, Khan KS. Non-anaemic iron deficiency - a disease looking for recognition of diagnosis: a systematic review. Eur J Haematol. 2016;96(6):618–628. doi:10.1111/ejh.12645
  • Brownlie T, Utermohlen V, Hinton PS, Giordano C, Haas JD. Marginal iron deficiency without anemia impairs aerobic adaptation among previously untrained women. Am J Clin Nutr. 2002;75(4):734–742. doi:10.1093/ajcn/75.4.734
  • Bruner AB, Joffe A, Duggan AK, Casella JF, Brandt J. Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls. Lancet. 1996;348(9033):992–996. doi:10.1016/S0140-6736(96)02341-0
  • Verdon F. Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trial. BMJ. 2003;326(7399):1124. doi:10.1136/bmj.326.7399.1124
  • Vaucher P, Druais PL, Waldvogel S, Favrat B. Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: a randomized controlled trial. CMAJ. 2012;184(11):1247–1254. doi:10.1503/cmaj.110950
  • Amrein K, Macher S, Schröck M, Schlenke P, Drexler C. Iron deficiency in blood donors: perceptions and management among general practitioners and internists. Transfusion. 2017;57(10):2548–2549. doi:10.1111/trf.14297
  • Lobier M, Castrén J, Niittymäki P, Palokangas E, Partanen J, Arvas M. The effect of donation activity dwarfs the effect of lifestyle, diet and targeted iron supplementation on blood donor iron stores. PLoS One. 2019;14(8):e0220862. doi:10.1371/journal.pone.0220862
  • Cançado RD, Chiattone CS, Alonso FF, Langhi Júnior DM, Alves R. Iron deficiency in blood donors. Sao Paulo Med J. 2001;119(4):132–134. doi:10.1590/S1516-31802001000400003
  • Cable RG, Glynn SA, Kiss JE, et al. Iron deficiency in blood donors: the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion. 2012;52(4):702–711. doi:10.1111/j.1537-2995.2011.03401.x
  • Allen RP. Iron, RLS and blood donations. Sleep Med. 2004;5(2):113–114. doi:10.1016/j.sleep.2003.12.005
  • Bryant BJ, Yau YY, Arceo SM, Hopkins JA, Leitman SF. Ascertainment of iron deficiency and depletion in blood donors through screening questions for pica and restless legs syndrome. Transfusion. 2013;53(8):1637–1644. doi:10.1111/trf.12061
  • Liu H, Burns RT, Spencer BR, Page GP, Mast AE. For the NHLBI Recipient Epidemiology Donor Evaluation Study (REDS)‐III. Demographic, clinical, and biochemical predictors of pica in a large cohort of blood donors. Transfusion. 2021;61(7):2090–2098. doi:10.1111/trf.16409
  • Alvarez-Ossorio K, Kluter S. Low ferritin levels indicate the need for iron supplementation: strategy to minimize iron-depletion in regular blood donors. Transfus Med. 2000;10(2):107–112. doi:10.1046/j.1365-3148.2000.00239.x
  • Fillet A, Martinaud C, Malard L, et al. Iron deficiency among French whole‐blood donors: first assessment and identification of predictive factors. Vox Sang. 2021;116(1):42–52. doi:10.1111/vox.12991
  • Coad J, Pedley K. Iron deficiency and iron deficiency anemia in women. Scand J Clin Lab Invest. 2014;74(sup244):82–89. doi:10.3109/00365513.2014.936694
  • Patel EU, White JL, Bloch EM, et al. Association of blood donation with iron deficiency among adolescent and adult females in the United States: a nationally representative study. Transfusion. 2019;59(5):1723–1733. doi:10.1111/trf.15179
  • Badami KG, Taylor K. Iron status and risk-profiling for deficiency in New Zealand blood donors. N Z Med J. 2008;121(1274):50–60.
  • Vassallo RR, Hilton JF, Bravo MD, Vittinghoff E, Custer B, Kamel H. Recovery of Iron Stores After Adolescents Donate Blood. Pediatrics. 2020;146(1):e20193316. doi:10.1542/peds.2019-3316
  • Di Angelantonio E, Thompson SG, Kaptoge S, et al. Efficiency and safety of varying the frequency of whole blood donation (INTERVAL): a randomised trial of 45 000 donors. Lancet. 2017;390(10110):2360–2371. doi:10.1016/S0140-6736(17)31928-1
  • Salvin HE, Pasricha SR, Marks DC, Speedy J. Iron deficiency in blood donors: a national cross-sectional study. Transfusion. 2014;54(10):2434–2444. doi:10.1111/trf.12647
  • Karp JK, King KE. International variation in volunteer whole blood donor eligibility criteria. Transfusion. 2010;50(2):507–513. doi:10.1111/j.1537-2995.2009.02392.x
  • AABB. Updated Strategies to Limit or Prevent Iron Deficiency in Blood Donors. Bethesda, MD: AABB Association Bulletin AABB; 2017.
  • O’Meara A, Infanti L, Stebler C, et al. The value of routine ferritin measurement in blood donors. Transfusion. 2011;51(10):2183–2188. doi:10.1111/j.1537-2995.2011.03148.x
  • Goldman M, Magnussen K, Gorlin J, et al. International Forum regarding practices related to donor haemoglobin and iron. Vox Sang. 2016;111(4):449–455. doi:10.1111/vox.12431
  • Duggan F, O’Sullivan K, Power JP, Healy M, Murphy WG. Serum ferritin in plateletpheresis and whole blood donors. Transfus Apher Sci. 2016;55(1):159–163. doi:10.1016/j.transci.2016.06.004
  • Chinigi Sab P, Kaur G, Kaur P, et al. Assessment of serum iron stores in regular plateletpheresis donors. Transfus Apher Sci. 2022;61(1):103291. doi:10.1016/j.transci.2021.103291
  • O’Meara A, Infanti L, Sigle J, Stern M, Buser A. Switching iron-deficient whole blood donors to plateletpheresis. Transfusion. 2012;52(10):2183–2188. doi:10.1111/j.1537-2995.2012.03584.x
  • Radtke H, Meyer T, Kalus U, et al. Rapid identification of iron deficiency in blood donors with red cell indexes provided by Advia 120. Transfusion. 2005;45(1):5–10. doi:10.1111/j.1537-2995.2005.04205.x
  • Prinsze FJ, Groot R, Timmer TC, Zalpuri S, Hurk K. Donation‐induced iron depletion is significantly associated with low hemoglobin at subsequent donations. Transfusion. 2021;61(12):3344–3352. doi:10.1111/trf.16688
  • Gorlin J, Katz L, Elsmore D, et al. Prevalence of blood donor iron deficiency and feasibility ferritin-based iron replacement: a blood collection agency-based study. Vox Sang. 2016;111(2):206–208. doi:10.1111/vox.12408
  • Mast AE. Low hemoglobin deferral in blood donors. Transfus Med Rev. 2014;28(1):18–22. doi:10.1016/j.tmrv.2013.11.001
  • Kotzé SR, Pedersen OB, Petersen MS, et al. Predictors of hemoglobin in Danish blood donors: results from the Danish Blood Donor Study. Transfusion. 2015;55(6):1303–1311. doi:10.1111/trf.13011
  • Gestsdottir E, Magnusson MK, Lund SH, et al. Monitoring iron stores in Icelandic blood donors from 1997 through 2019. Transfus Med. 2022;32(2):128–134. doi:10.1111/tme.12856
  • Goldman M, Yi Q, Steed T, O’Brien SF. Changes in minimum hemoglobin and interdonation interval: impact on donor hemoglobin and donation frequency. Transfusion. 2019;59(5):1734–1741. doi:10.1111/trf.15155
  • Goldman M, Uzicanin S, Scalia J, Scalia V, O’Brien SF. Impact of informing donors of low ferritin results. Transfusion. 2016;56(9):2193–2198. doi:10.1111/trf.13691
  • France JL, France CR, Rebosa M, Shaz BH, Kessler DA. Promoting awareness of donation‐related iron depletion among high risk blood donors. Transfusion. 2021;61(12):3353–3360. doi:10.1111/trf.16694
  • Blake JT, O’Brien SF, Goldman M. The impact of donor ferritin testing on blood availability in Canada. Vox Sang. 2022;117(1):17–26. doi:10.1111/vox.13126
  • Baart AM, de Kort WLAM, Moons KGM, Atsma F, Vergouwe Y. Zinc protoporphyrin levels have added value in the prediction of low hemoglobin deferral in whole blood donors. Transfusion. 2013;53(8):1661–1669. doi:10.1111/j.1537-2995.2012.03957.x
  • Tiwari AK, Bhardwaj G, Arora D, et al. Applying newer parameter Ret‐He (reticulocyte haemoglobin equivalent) to assess latent iron deficiency (LID) in blood donors–study at a tertiary care hospital in India. Vox Sang. 2018;113(7):639–646. doi:10.1111/vox.12700
  • Boulton C, Inskip P. A study of the iron and HFE status of blood donors, including a group who failed the initial screen for anaemia. Br J Haematol. 2000;108(2):434–439. doi:10.1046/j.1365-2141.2000.01878.x
  • Alexander HD, Sherlock JP, Bharucha C. Red cell indices as predictors of iron depletion in blood donors. Clin Lab Haematol. 2000;22(5):253–258. doi:10.1046/j.1365-2257.2000.00323.x
  • Amir N, Md Noor S, Subbiah I, Osman M, Seman Z. Percentage of hypochromic red cells as a potential screening test to evaluate iron status in blood donors. Int J Lab Hem. 2019;41(3):418–423. doi:10.1111/ijlh.13009
  • Aardal Eriksson E, Mobäck C, Jakobsson S, Hoffmann JJML. Iron depletion in blood donors – have extended erythrocyte and reticulocyte parameters diagnostic utility? Transfus Apher Sci. 2015;53(1):76–81. doi:10.1016/j.transci.2015.03.011
  • Beck KL, Conlon CA, Kruger R, et al. Blood Donation, Being Asian, and a History of Iron Deficiency Are Stronger Predictors of Iron deficiency than dietary patterns in premenopausal women. Biomed Res Int. 2014;2014:1–7. doi:10.1155/2014/652860
  • Cable RG, Glynn SA, Kiss JE, et al. Iron deficiency in blood donors: analysis of enrollment data from the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion. 2011;51(3):511–522. doi:10.1111/j.1537-2995.2010.02865.x
  • Sayers MH. Iron supplementation? Ferritin screening? Why questions persist. Transfusion. 2019;59(5):1616–1619. doi:10.1111/trf.15303
  • Adu P, Banom S, Amediku MK, Amoaning RE, Quarshie AAA, Simpong DL. Poor iron store recovery in voluntary blood donors in the northern zone of Ghana; a five-month three-centre cohort study. Transfus Apher Sci. 2021;60(2):103040. doi:10.1016/j.transci.2020.103040
  • Wood EM, Miller JP. Low ferritin levels indicate the need for iron supplementation: strategy to minimize iron depletion in regular blood donors. Transfus Med. 2001;11(1):59–60. doi:10.1046/j.1365-3148.2001.00276.x
  • Kiss JE, Brambilla D, Glynn SA, et al. Oral Iron supplementation after blood donation: a randomized clinical trial. JAMA. 2015;313(6):575. doi:10.1001/jama.2015.119
  • Gordeuk V, Brittenham G, Bravo J, Hughes M, Keating L. Prevention of iron deficiency with carbonyl iron in female blood donors. Transfusion. 1990;30(3):239–245. doi:10.1046/j.1537-2995.1990.30390194345.x
  • Marks DC, Speedy J, Robinson KL, et al. An 8-week course of 45 mg of carbonyl iron daily reduces iron deficiency in female whole blood donors aged 18 to 45 years: results of a prospective randomized controlled trial. Transfusion. 2014;54(3pt2):780–788. doi:10.1111/trf.12464
  • Birgegård G, Schneider K, Ulfberg J. High incidence of iron depletion and restless leg syndrome (RLS) in regular blood donors: intravenous iron sucrose substitution more effective than oral iron. Vox Sang. 2010;99(4):354–361. doi:10.1111/j.1423-0410.2010.01368.x
  • Bryant BJ, Yau YY, Arceo SM, Daniel-Johnson J, Hopkins JA, Leitman SF. Iron replacement therapy in the routine management of blood donors. Transfusion. 2012;52(7):1566–1575. doi:10.1111/j.1537-2995.2011.03488.x
  • Krayenbuehl PA, Battegay E, Breymann C, Furrer J, Schulthess G. Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration. Blood. 2011;118(12):3222–3227. doi:10.1182/blood-2011-04-346304
  • Gybel-Brask M, Seeberg J, Thomsen LL, Johansson PI. Intravenous iron isomaltoside improves hemoglobin concentration and iron stores in female iron-deficient blood donors: a randomized double-blind placebo-controlled clinical trial. Transfusion. 2018;58(4):974–981. doi:10.1111/trf.14521
  • Cable RG, Brambilla D, Glynn SA, et al. Effect of iron supplementation on iron stores and total body iron after whole blood donation. Transfusion. 2016;56(8):2005–2012. doi:10.1111/trf.13659
  • Chiamchanya N. Rapid recovery time of hemoglobin level in female regular blood donors with ferrous fumarate and high dose of ascorbic acid supplement. J Med Assoc Thai. 2013;96(2):165–171.
  • Drexler C, Macher S, Lindenau I, et al. High-dose intravenous versus oral iron in blood donors with iron deficiency: the IronWoMan randomized, controlled clinical trial. Clinical Nutrition. 2020;39(3):737–745. doi:10.1016/j.clnu.2019.03.025
  • Mast AE, Bialkowski W, Bryant BJ, et al. A randomized, blinded, placebo-controlled trial of education and iron supplementation for mitigation of iron deficiency in regular blood donors. Transfusion. 2016;56(6pt2):1588–1597. doi:10.1111/trf.13469
  • Radtke H, Tegtmeier J, Röcker L, Salama A, Kiesewetter H. Daily doses of 20 mg of elemental iron compensate for iron loss in regular blood donors: a randomized, double-blind, placebo-controlled study. Transfusion. 2004;44(10):1427–1432. doi:10.1111/j.1537-2995.2004.04074.x
  • Radtke H, Tegtmeier J, Röcker L, Salama A, Kiesewetter H. Compensating for iron loss in regular blood donors using ferrous gluconate and ascorbic acid. Transfusion. 2005;45(7):1236–1237. doi:10.1111/j.1537-2995.2005.00183.x
  • Radtke H, Mayer B, Röcker L, Salama A, Kiesewetter H. Iron supplementation and 2-unit red blood cell apheresis: a randomized, double-blind, placebo-controlled study. Transfusion. 2004;44(10):1463–1467. doi:10.1111/j.1537-2995.2004.04045.x
  • Macher S, Herster C, Holter M, et al. The effect of parenteral or oral iron supplementation on fatigue, sleep, quality of life and restless legs syndrome in Iron-deficient blood donors: a secondary analysis of the IronWoMan RCT. Nutrients. 2020;12(5):1313. doi:10.3390/nu12051313
  • Vassallo RR. Donor iron depletion in context. Transfusion. 2021;61(1):318–321. doi:10.1111/trf.16219
  • Kanias T, Stone M, Page GP, et al. Frequent blood donations alter susceptibility of red blood cells to storage‐ and stress‐induced hemolysis. Transfusion. 2019;59(1):67–78. doi:10.1111/trf.14998
  • Roussel C, Morel A, Dussiot M, et al. Rapid clearance of storage-induced microerythrocytes alters transfusion recovery. Blood. 2021;137(17):2285–2298. doi:10.1182/blood.2020008563
  • Bialkowski W, Bryant BJ, Schlumpf KS, et al. The strategies to reduce iron deficiency in blood donors randomized trial: design, enrolment and early retention. Vox Sang. 2015;108(2):178–185. doi:10.1111/vox.12210
  • Chueca M, Bouvet G, Duron-Martinaud S, Doyen M, Poirrier L, Martinaud C. Iron-deficiency among blood donors: donors’ opinion on iron supplementation strategy. Transfus Clin Biol. 2020;27(4):218–221. doi:10.1016/j.tracli.2020.08.004
  • Shah AA, Donovan K, Seeley C, et al. Risk of infection associated with administration of intravenous Iron: a systematic review and meta-analysis. JAMA Netw Open. 2021;4(11):e2133935. doi:10.1001/jamanetworkopen.2021.33935
  • Kaspersen KA, Dinh KM, Mikkelsen S, et al. Oral iron supplementation is not associated with short-term risk of infections: results from the Danish blood donor study. Transfusion. 2019;59(6):2030–2038. doi:10.1111/trf.15221
  • Shannon M. Ingestion of Toxic Substances by Children. N Engl J Med. 2000;342(3):186–191. doi:10.1056/NEJM200001203420307
  • Litovitz TL, Klein-Schwartz W, Caravati EM, Youniss J, Crouch B, Lee S. 1998 annual report of the American association of poison control centers toxic exposure surveillance system. Am J Emerg Med. 1999;17(5):435–487. doi:10.1016/S0735-6757(99)90254-1
  • Pasricha SR, Marks DC, Salvin H, et al. Postdonation iron replacement for maintaining iron stores in female whole blood donors in routine donor practice: results of two feasibility studies in Australia. Transfusion. 2017;57(8):1922–1929. doi:10.1111/trf.14173
  • Karregat J, Sweegers MG, Quee FA, et al. Ferritin-guided iron supplementation in whole blood donors: optimal dosage, donor response, return and efficacy (FORTE)—a randomised controlled trial protocol. BMJ Open. 2022;12(3):e056316. doi:10.1136/bmjopen-2021-056316